Purchase Order 75N92026P00031
- Not listed
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a Delivery Order contract to Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, for maintenance and service support of an LSRFortessa flow cytometry instrument. Valued at $52,736.04 with a firm fixed-price structure, this contract will support the NHLBI's Flow Cytometry Core facility, a state-of-the-art resource dedicated to enabling biomedical research conducted by NHLBI investigators. The...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order valued at $53,205.12 to Becton, Dickinson and Company (BD Biosciences) on January 1, 2026, for maintenance coverage of its LSRFortessa flow cytometry system and throughput sampler. This firm fixed-price contract, which serves as a child delivery order under a larger indefinite delivery vehicle, will be performed in San Jose, California and is scheduled for completion by December 31, 2026. The award was made without...
- This is a firm fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The $21,900.48 contract is for a service contract to maintain the NHLBI's FACS Fortessa X-20 SORP flow cytometry instrument. This contract does not have a set-aside designation, indicating it was competed on a full and open basis. BD, a...
- On April 10, 2025, the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health, awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $17,000.13 to Becton, Dickinson and Company (BD), through its BD Biosciences division. The contract, which carries no small business set-aside designation, will support the NHLBI Flow Cytometry Core facility located in Franklin Lakes, New Jersey. Under this award, BD will supply antibodies and...
- This is a $51,828.84 firm-fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance of Fortessa flow cytometer analyzers. The contract has a period of performance through January 12, 2026. BD is a global medical technology company that provides a range of biomedical research and clinical instruments, including flow cytometers, as well as...
- The National Heart, Lung, and Blood Institute (NHLBI), part of the Department of Health and Human Services, awarded a $42,476.04 firm fixed-price purchase order contract to Becton, Dickinson and Company for maintenance of a BD Fortessa Flow Cytometer Analyzer. The contract provides comprehensive service including unlimited phone support, emergency repairs, parts and labor coverage, and preventative maintenance. Becton, Dickinson is the sole source provider as the manufacturer of the...
- This federal contract award was made by the National Heart Lung and Blood Institute, an agency of the National Institutes of Health, to Becton, Dickinson and Company (BD) for the procurement of flow cytometry equipment, instrumentation, and related supplies. The $6,454.00 firm-fixed-price contract was awarded on May 7, 2015, with a completion date of May 31, 2015. The award does not indicate a set-aside designation, suggesting BD competed against other large medical technology manufacturers...
- This federal contract award was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Becton, Dickinson and Company (BD) for a service contract to maintain the performance of a FACSCanto flow cytometry instrument used daily by the Laboratory of Molecular Immunology. The contract is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call with a ceiling value of $10,936.32 and a period of performance from August 18, 2017 to August 17, 2018. This award did not...
- This is a $199,847.40 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Becton, Dickinson and Company (BD) for the maintenance of FACSYMPHONY A5 instruments. The contract has an ultimate completion date of September 30, 2025. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical applications, including flow cytometry, cell imaging, and genomics...
- This is a $700,580.86 firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for a service maintenance plan for BD LSR Fortessa SORP flow cytometers with high-throughput and BD Influx flow cytometers with lasers. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 9, 2017 without a set-aside designation, indicating BD's...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $22,107.60 firm fixed-price purchase order to Becton, Dickinson and Company's BD Biosciences division for flow cytometry core instrument service contract support. The contract, which commenced February 1, 2026 and concludes January 31, 2027, provides maintenance and technical support services for the FACS (Fluorescence-Activated Cell Sorting) Core facility located in San Jose, California. This state-of-the-art facility supports biomedical research conducted by NHLBI investigators, enabling critical flow cytometry analysis capabilities essential for immunology, hematology, and other research programs. The award was made on a full and open competitive basis with no small business set-aside designation. BD Biosciences is well-positioned to support this requirement, with extensive federal experience providing flow cytometry systems, reagents, and maintenance services across multiple National Institutes of Health components and federal agencies. The company maintains numerous indefinite delivery contracts with the Department of Veterans Affairs and NIH for flow cytometry equipment and supplies, demonstrating established capability in supporting government research infrastructure. The NHLBI contract represents a continuation of the company's strategic role in maintaining advanced analytical equipment that facilitates federal biomedical research initiatives focused on cardiovascular, pulmonary, and blood-related diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.1k | 12/30/25 |